This announcement is a separate document:
安信证券股份有限公司关于四川百利天恒药业股份有限公司首次公开发行股票并在科创板上市之战略配售事项之专项核查报告
Anxin Securities Co., Ltd. Special verification report on the strategic allotment of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. for initial public offering and listing in Science and Technology Innovation Board
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.